Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Strong Buy

Price to Earnings Rating

Buy

Analyst Rating

Strong Buy

Simple Moving Average

Strong Buy

Exponential Moving Average

Strong Buy

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Buy

Insider Trading

Neutral

Wall Street Data Solutions Rating

Strong Buy

S

DaVita Inc. (DVA)

Services-misc Health & Allied Services, Nec

https://www.davita.com

DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives about two thirds of U.S. sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.

2000 16TH STREET
DENVER, CO

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

10/31/1995

Market Cap

12,642,052,000

Shares Outstanding

91,270,000

Weighted SO

91,348,000

Total Employees

N/A

Upcoming Earnings

11/05/2024

Similar Tickers

SGRY --.--%

ACHC --.--%

ENSG --.--%

FSNUY --.--%

THC --.--%

HCA --.--%

USPH --.--%

AMED --.--%

OPCH --.--%

Beta

0.8680

Last Div

0.0000

Range

71.51-151.55

Chg

0.7200

Avg Vol

851058

Mkt Cap

12642052000

Exch

NYSE

Country

US

Phone

720 631 2100

DCF Diff

-139.9318

DCF

291.1318

Div Yield

0.0000

P/S

1.0094

EV Multiple

9.2651

P/FV

20.6888

Div Yield %

0.0000

P/E

15.2322

PEG

9.3670

Payout

0.0000

Current Ratio

1.1577

Quick Ratio

1.1153

Cash Ratio

0.1680

DSO

79.6518

DIO

5.2591

Op Cycle

84.9109

DPO

20.4753

CCC

64.4355

Gross Margin

0.2975

Op Margin

0.1510

Pretax Margin

0.1126

Net Margin

0.0686

Eff Tax Rate

0.1878

ROA

0.0505

ROE

0.9015

ROCE

0.1348

NI/EBT

0.6094

EBT/EBIT

0.7458

EBIT/Rev

0.1510

Debt Ratio

0.5374

D/E

14.4574

LT Debt/Cap

0.9284

Total Debt/Cap

0.9353

Int Coverage

6.4399

CF/Debt

0.1984

Equity Multi

26.9009

Rec Turnover

4.5824

Pay Turnover

17.8263

Inv Turnover

69.4032

FA Turnover

2.3024

Asset Turnover

0.7356

OCF/Share

20.8938

FCF/Share

14.6622

Cash/Share

6.0293

OCF/Sales

0.1450

FCF/OCF

0.7017

CF Coverage

0.1984

ST Coverage

1.9258

CapEx Coverage

3.3529

Div&CapEx Cov

3.3529

P/BV

20.6888

P/B

20.6888

P/S

1.0094

P/E

15.2322

P/FCF

9.9221

P/OCF

7.2117

P/CF

7.2117

PEG

9.3670

P/S

1.0094

EV Multiple

9.2651

P/FV

20.6888

DPS

0.0000

Latest Headlines (EST)

The Motley Fool Apr 30, 01:05 Prediction: Warren Buffett Will Reveal an Increase in This Massive Berkshire Hathaway Holding on May 3 The Motley Fool Apr 18, 22:13 Why DaVita Stock Got Rocked This Week The Motley Fool Feb 14, 22:25 Why DaVita Inc Stock Is Plummeting Today GlobeNewswire Inc. Dec 05, 00:30 Hemodialysis and Peritoneal Dialysis Market to Surpass Valuation of USD 142.97 Billion by 2031 | SkyQuest Technology Benzinga Dec 05, 00:30 Hemodialysis and Peritoneal Dialysis Market to Surpass Valuation of USD 142.97 Billion by 2031 | SkyQuest Technology The Motley Fool Jan 12, 18:44 Why Vera Therapeutics Stock Soared by 22% This Week The Motley Fool Jan 12, 18:44 Why Vera Therapeutics Stock Soared by 22% This Week The Motley Fool Jan 12, 18:44 Why Vera Therapeutics Stock Soared by 22% This Week The Motley Fool Jan 12, 18:44 Why Vera Therapeutics Stock Soared by 22% This Week The Motley Fool Jan 12, 18:44 Why Vera Therapeutics Stock Soared by 22% This Week The Motley Fool Jan 12, 18:44 Why Vera Therapeutics Stock Soared by 22% This Week The Motley Fool Jan 12, 18:44 Why Vera Therapeutics Stock Soared by 22% This Week The Motley Fool Jan 12, 18:44 Why Vera Therapeutics Stock Soared by 22% This Week The Motley Fool Jan 12, 18:44 Why Vera Therapeutics Stock Soared by 22% This Week The Motley Fool Jan 12, 18:44 Why Vera Therapeutics Stock Soared by 22% This Week The Motley Fool Jan 12, 18:44 Why Vera Therapeutics Stock Soared by 22% This Week MarketWatch Jan 06, 05:58 The Russell 2000 Index has soared, but you might be better off looking elsewhere for quality small-cap stocks MarketWatch Jan 02, 12:26 The Russell 2000 Index has soared, but you might be better off looking elsewhere for quality small-cap stocks MarketWatch Jan 02, 12:26 The Russell 2000 Index has soared, but you might be better off looking elsewhere for quality small-cap stocks Zacks Investment Research Dec 29, 11:45 Bayer (BAYRY) Loses 28% in 2023: What to Expect in 2024?

Revenue Product Segmentation